Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Apexigen, Inc. stock logo
APGN
Apexigen
$0.39
$0.39
$0.33
$8.28
$9.57M3.6967,731 shsN/A
PetMed Express, Inc. stock logo
PETS
PetMed Express
$3.62
-4.7%
$3.60
$2.90
$6.85
$74.78M0.76274,941 shs102,595 shs
7 Energy Stocks to Buy and Hold Forever Cover

With the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Apexigen, Inc. stock logo
APGN
Apexigen
0.00%0.00%0.00%0.00%0.00%
PetMed Express, Inc. stock logo
PETS
PetMed Express
-4.74%-6.22%+7.42%-17.16%-12.14%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Apexigen, Inc. stock logo
APGN
Apexigen
N/AN/AN/AN/AN/AN/AN/AN/A
PetMed Express, Inc. stock logo
PETS
PetMed Express
0.9801 of 5 stars
0.83.00.00.02.83.30.6
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Apexigen, Inc. stock logo
APGN
Apexigen
0.00
N/AN/AN/A
PetMed Express, Inc. stock logo
PETS
PetMed Express
1.50
Reduce$3.35-7.46% Downside

Current Analyst Ratings Breakdown

Latest APGN, CURY, SMWH, and PETS Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
4/17/2025
PetMed Express, Inc. stock logo
PETS
PetMed Express
Morgan Stanley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetUnderweight ➝ Underweight$3.50 ➝ $3.20
(Data available from 5/24/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Apexigen, Inc. stock logo
APGN
Apexigen
N/AN/AN/AN/A($0.09) per shareN/A
PetMed Express, Inc. stock logo
PETS
PetMed Express
$247.01M0.30$0.02 per share193.50$4.66 per share0.78
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Apexigen, Inc. stock logo
APGN
Apexigen
-$32.07MN/A0.00N/AN/A-614.82%-133.30%N/A
PetMed Express, Inc. stock logo
PETS
PetMed Express
-$7.46M$0.01362.36120.67N/A0.14%0.37%0.23%6/10/2025 (Estimated)

Latest APGN, CURY, SMWH, and PETS Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
6/10/2025Q4 2025
PetMed Express, Inc. stock logo
PETS
PetMed Express
-$0.06N/AN/AN/A$54.00 millionN/A
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Apexigen, Inc. stock logo
APGN
Apexigen
N/AN/AN/AN/AN/A
PetMed Express, Inc. stock logo
PETS
PetMed Express
$0.9024.86%N/A9,000.00%N/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Apexigen, Inc. stock logo
APGN
Apexigen
N/A
0.82
0.82
PetMed Express, Inc. stock logo
PETS
PetMed Express
N/A
1.43
1.18

Institutional Ownership

CompanyInstitutional Ownership
Apexigen, Inc. stock logo
APGN
Apexigen
13.65%
PetMed Express, Inc. stock logo
PETS
PetMed Express
73.33%

Insider Ownership

CompanyInsider Ownership
Apexigen, Inc. stock logo
APGN
Apexigen
19.20%
PetMed Express, Inc. stock logo
PETS
PetMed Express
1.10%
CompanyEmployeesShares OutstandingFree FloatOptionable
Apexigen, Inc. stock logo
APGN
Apexigen
1124.86 million20.09 millionNot Optionable
PetMed Express, Inc. stock logo
PETS
PetMed Express
21020.66 million20.43 millionOptionable

Recent News About These Companies

PetMeds Reviews
Morgan Stanley Sticks to Their Sell Rating for Petmed Express (PETS)
PetMed Express appoints Peter Batushansky to board of directors
Pets at Home perks up on takeover speculation

New MarketBeat Followers Over Time

Media Sentiment Over Time

Apexigen stock logo

Apexigen NASDAQ:APGN

Apexigen, Inc., a clinical-stage biopharmaceutical company, discovers and develops antibody therapeutics for oncology. It develops a pipeline of product candidates, including APX005M, a humanized agonist antibody that is in Phase II clinical development for the treatment of solid tumors, such as melanoma, esophageal and gastroesophageal junction, sarcoma, and ovarian cancers in combination with immunotherapy, chemotherapy, radiation therapy, and cancer vaccines; and APX601, a humanized antagonist antibody that is in Phase I/II clinical trial for the treatment of multiple tumor indications, as well as APX801, an NK cell engager to activate natural killer cells to killing of tumor cells. Apexigen, Inc. was founded in 2010 and is headquartered in San Carlos, California.

PetMed Express stock logo

PetMed Express NASDAQ:PETS

$3.62 -0.18 (-4.74%)
Closing price 05/23/2025 04:00 PM Eastern
Extended Trading
$3.64 +0.01 (+0.41%)
As of 05/23/2025 07:53 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

PetMed Express, Inc., together with its subsidiaries, operates as a pet pharmacy in the United States. The company markets prescription and non-prescription pet medications, health products, and other supplies for dogs, cats, and horses. It offers non-prescription medications and supplies, such as flea and tick control products, bone and joint care products, vitamins, treats, nutritional supplements, hygiene products, and household pet supplies; and prescription medications, including heartworm preventatives, flea and tick preventatives, arthritis, dermatitis, thyroid, diabetes, pain medications, heart/blood pressure, and other specialty medications, as well as generic substitutes. The company also sells food, beds, crates, stairs, and other pet supplies. It sells its products through its Internet website; mobile app; customer support center; and direct mail/print, which includes brochures and postcards. The company was incorporated in 1996 and is headquartered in Delray Beach, Florida.